Orlistat will shortly be available to purchase from community pharmacies following a successful application to regulatory authorities. This product launch has gained significant media attention (BBC).
Each Alli® capsule will contain 60mg of orlistat and is recommended for people who are overweight (BMI > 28), want to lose weight, and will commit to healthier eating. The product is expected to retail for approximately £50 for a months supply.
This over-the-counter (OTC) product is half the strength of the prescription only version (Xenical®) but concerns have been raised about the potential for side effects if lifestyle changes are not implemented.
Action: Clinicians should be aware of the wider availability of this product.
|« AF not prevented by valsartan||April NICE Guidance »|